Showing results (41-50 of 536) with videos related to
Sort By:
Pageof 54
The Journal of Biological Chemistry|January 16, 1999
Selected subunits of the cytosolic chaperonin associate with microtubules assembled in vitroA Roobol, Z P Sahyoun, M J CardenThe Prostate|January 3, 2006
A comparison of first and repeat (four years later) prostate cancer screening in a randomized cohort of a symptomatic men aged 55-75 years using a biopsy indication of 3.0 ng/ml (results of ERSPC, Rotterdam)Monique J Roobol, Fritz H Schröder, Ries Kranse, et al.British Journal of Cancer|September 1, 1987
5-Azacytidine and 5-aza-2'-deoxycytidine behave as different antineoplastic agents in B16 melanomaR Cortvrindt, J Bernheim, N Buyssens, et al.Nature Reviews. Urology|December 21, 2016
The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USAKatherine Fleshner, Sigrid V Carlsson, Monique J RoobolEuropean Journal of Biochemistry|November 1, 1981
Partial purification of the messenger RNA for eukaryotic elongation factor Tu from Artemia salinaF J van Hemert, K Roobol, W MöllerClinical Biochemistry|January 7, 1999
Analytical issues on prostate-specific antigen in relation to prostate cancer screeningB G Blijenberg, M Roobol, F H SchröderNature Reviews. Urology|May 29, 2013
Defining the threshold for significant versus insignificant prostate cancerTheo H Van der Kwast, Monique J RoobolAsian Journal of Urology|December 22, 2017
Prostate cancer screening in Europe and AsiaKai Zhang, Chris H Bangma, Monique J RoobolEuropean Urology|September 13, 2023
Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-UHendrik Van Poppel, Monique J Roobol, Arunah ChandranEuropean Journal of Cancer (Oxford, England : 1990)|November 5, 2010
Epilogue: different approaches for prostate cancer screening in the EU?Fritz H Schröder, Louis Denis, Monique J RoobolPageof 54